MedTrace Logo

STITCH (Simplified Therapeutic Intervention To Control Hypertension)

NCT00129909 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 2081

Last updated 2012-06-14

No results posted yet for this study

Summary

The objective of this study is to assess whether the implementation of a primary treatment algorithm using a fixed dose combination therapy will improve the management of hypertension when compared to usual management.

Conditions

Interventions

DRUG

fixed dose combination therapy

Sponsors & Collaborators

  • Pfizer

    collaborator INDUSTRY

  • University of Western Ontario, Canada

    lead OTHER

Principal Investigators

  • Ross D Feldman, MD · Western University, Canada

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-05-31
Primary Completion
2006-09-30
Completion
2007-01-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00129909 on ClinicalTrials.gov